Fundraising Fox
Biopsense
Jyväskylä, FI · 1 known investors
Find your way into Biopsense
Sign up to see every warm intro you have to Biopsense
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Biopsense team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
BiopSense develops an automated cartridge for extracting cell-free nucleic acids (DNA, RNA, cells, proteins) from large blood volumes without centrifugation, aimed at simplifying liquid biopsy sample preparation and transport for cancer diagnostics and monitoring. It serves oncology clinical laboratories and healthcare providers to enable non-invasive cancer treatment monitoring and personalization.
Founders & leadership
JK
Juha KononenMedical Director, Founder (MD)
MT
Marja TiirolaCSO, Founder (Prof.)Marja Tiirola holds a Ph.D. in molecular biology and a permanent professorship at a Finnish university; she founded BiopSense in 2019 to develop automated sample preparation technologies for liquid biopsy diagnostics, and has received European funding including an ERC Consolidator Grant and the first Finnish EIC Transition grant.
PK
Petri KallbergCEO (B.Eng.)Petri Kallberg holds a B.Eng. and is CEO of Biopsense, which develops automated cartridges for extracting cell-free nucleic acids from blood samples to support liquid biopsy applications in oncology diagnostics. He has prior experience in product management, engineering, business development, and strategic partnerships across connected technologies and digital services.
ER
Elina RuuhilehtoLaboratory Director (PhD)Elina Ruuhilehto holds a PhD in biosciences and chemistry with doctoral research in receptor-virus interactions and post-doctoral work in oncology diagnostic method development. She joined BiopSense as Laboratory Director in 2020, where she has managed clinical laboratory operations, IVD medical device development, and quality and safety functions.
Investors · 1
Frequently asked questions
- What does Biopsense do?
- BiopSense develops an automated cartridge for extracting cell-free nucleic acids (DNA, RNA, cells, proteins) from large blood volumes without centrifugation, aimed at simplifying liquid biopsy sample preparation and transport for cancer diagnostics and monitoring. It serves oncology clinical laboratories and healthcare providers to enable non-invasive cancer treatment monitoring and personalization.
- Who founded Biopsense?
- Biopsense was founded by Juha Kononen, Marja Tiirola, Veli-Mikko Puupponen.
- Who are Biopsense's investors?
- Biopsense's investors include Midinvest Management Oy.
- Where is Biopsense headquartered?
- Biopsense is headquartered in Jyväskylä, FI.